These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
11. [Combination effect of arbekacin and cefepime on mixed culture of MRSA and P. aeruginosa]. Araake M, Hara T, Miyata A, Tani M, Ogawa H. Jpn J Antibiot; 2001 Feb; 54(2):69-78. PubMed ID: 11338680 [Abstract] [Full Text] [Related]
12. [Staggered intensive chemotherapy using arbekacin, fosfomycin and ceftazidime on polymicrobial infections involving MRSA]. Tanaka T, Iida-Tanaka K, Takahara J, Fujioka Y, Tamura T, Yamanoi Y, Houjou S, Takahashi T, Miki S, Nakamura Y. Jpn J Antibiot; 1994 Jun; 47(6):790-7. PubMed ID: 8072188 [Abstract] [Full Text] [Related]
18. Antimicrobial activity of arbekacin, a new aminoglycoside antibiotic, against methicillin-resistant Staphylococcus aureus. Inoue M, Nonoyama M, Okamoto R, Ida T. Drugs Exp Clin Res; 1994 Jun; 20(6):233-9. PubMed ID: 7758395 [Abstract] [Full Text] [Related]
19. Susceptibility of methicillin-resistant Staphylococcus aureus clinical isolates to various antimicrobial agents. II. Isolation of arbekacin-resistant strain. Inouye Y, Morifuji K, Masumi N, Nakamura S, Takesue Y, Santou T, Yokoyama T. Hiroshima J Med Sci; 1992 Dec; 41(4):79-85. PubMed ID: 1293073 [Abstract] [Full Text] [Related]